Nuvation Bio Files Proxy Statement for Annual Meeting
Ticker: NUVB · Form: DEF 14A · Filed: Jul 30, 2024 · CIK: 1811063
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
TL;DR
Nuvation Bio's proxy statement is out for the Sept 3rd meeting - vote your shares!
AI Summary
Nuvation Bio Inc. filed its definitive proxy statement (DEF 14A) on July 30, 2024, for its annual meeting on September 3, 2024. The filing details executive compensation, board nominations, and other corporate governance matters. The company, formerly known as Panacea Acquisition Corp., is focused on developing novel cancer therapies.
Why It Matters
This filing provides shareholders with crucial information regarding company leadership, voting matters, and executive compensation, enabling informed participation in corporate governance.
Risk Assessment
Risk Level: low — This is a routine proxy filing providing information to shareholders and does not inherently introduce new financial risks.
Key Numbers
- 001-39351 — SEC File Number (Nuvation Bio's registration with the SEC)
Key Players & Entities
- Nuvation Bio Inc. (company) — Registrant
- Panacea Acquisition Corp. (company) — Former Company Name
- 0001193125-24-188838 (filing_id) — Accession Number
- 20240730 (date) — Filing Date
- 20240903 (date) — Meeting Date
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this DEF 14A filing is to provide shareholders with information required for the annual meeting, including details on executive compensation, director nominations, and other corporate governance matters.
When is the Nuvation Bio Inc. annual meeting scheduled?
The annual meeting for Nuvation Bio Inc. is scheduled for September 3, 2024.
What was Nuvation Bio Inc.'s former name?
Nuvation Bio Inc. was formerly known as Panacea Acquisition Corp.
On what date was this definitive proxy statement filed?
This definitive proxy statement was filed on July 30, 2024.
What is Nuvation Bio Inc.'s Standard Industrial Classification code?
Nuvation Bio Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 4,977 words · 20 min read · ~17 pages · Grade level 11.2 · Accepted 2024-07-30 16:01:55
Filing Documents
- d843251ddef14a.htm (DEF 14A) — 521KB
- g843251dsp64b.jpg (GRAPHIC) — 4KB
- g843251g13f05.jpg (GRAPHIC) — 84KB
- g843251g24c03.jpg (GRAPHIC) — 28KB
- g843251g43l72.jpg (GRAPHIC) — 6KB
- g843251g90k01.jpg (GRAPHIC) — 25KB
- g843251g91t20.jpg (GRAPHIC) — 25KB
- 0001193125-24-188838.txt ( ) — 760KB
Executive Compensation
Executive Compensation 30 Proposal 4Conversion of Series A Preferred Stock to Class AStock 39 Proposal 5Approval of an Adjournment of the Annual Meeting, if Necessary or Appropriate, to Solicit Additional Proxies 46
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 47 Anti-Hedging and Anti-Pledging Policy 50 Section 16(A) Beneficial Ownership Reporting Compliance 50 Securities Authorized for Issuance Under Equity CompensationPlans 50 Certain Relationships and Related-Person Transactions 51 Certain Matters Relating to Proxy Materials and AvailableInformation 53 Other Matters 54 i Table of Contents NUVATION BIO INC. PROXY STATEMENT FOR ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON SEPTEMBER 3, 2024 QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING Why am I receiving these materials? We have sent you these proxy materials because the Board of Directors of Nuvation Bio Inc. (the Board) is soliciting your proxy to vote at the 2024 Annual Meeting of Stockholders, including at any adjournments or postponements of the meeting. You are invited to attend the Annual Meeting online to vote on the proposals described in this proxy statement. However, you do not need to attend the meeting to vote your shares. Instead, you may simply complete, sign and return the enclosed proxy card, or follow the instructions below to submit your proxy over the telephone or through the internet. We intend to mail these proxy materials on or about July 30, 2024 to all stockholders of record entitled to vote at the Annual Meeting. How do I attend the Annual Meeting? The Annual Meeting will be held through a live webcast at www.virtualshareholdermeeting.com/NUVB2024. You will not be able to attend the Annual Meeting in person. If you attend the Annual Meeting online, you will be able to vote and submit questions, at www.virtualshareholdermeeting.com/NUVB2024. You are entitled to attend the Annual Meeting if you were a stockholder as of the close of business on July 29, 2024, the record date. To be admitted to the Annual Meeting, you will need to visit www.virtualshareholdermeeting.com/NUVB2024 and enter th